Author:
Le Guevel Rémy,Pakdel Farzad
Publisher
Oxford University Press (OUP)
Subject
Obstetrics and Gynaecology,Rehabilitation,Reproductive Medicine
Reference32 articles.
1. Arukwe, A., Grotmol, T., Haugen, T.B. et al. (1999) Fish model for assessing the in vivo estrogenic potency of the mycotoxin zearalenone and its metabolites. Sci. Total. Environ., 236, 153–161.
2. Bories G. F. and Fernandez-Suarez A. (1989) Profiling of free and conjugated [3H]zeranol metabolites in pig plasma. J. Chromatogr., 489, 191–197.
3. Bories, G.F., Perdu-Durand, E.F., Sutra, J.F. and Tulliez, J.E. (1991) Evidence for glucuronidation and sulfation of zeranol and metabolites (taleranol and zearalanone) by rat and pig hepatic subfractions. Drug Metab. Dispos., 19, 140–143.
4. Chetrite, G. and Pasqualini, J.R. (1997) Steroid sulphotransferase and 17beta-hydroxysteroid dehydrogenase activities in Ishikawa human endometrial adenocarcinoma. J. Steroid Biochem. Mol. Biol., 61, 27–34.
5. Everett, D.J., Perry, C.J., Scott, K.A. et al. (1987) Estrogenic potencies of resorcylic acid lactones and 17beta-estradiol in female rats. J. Toxicol. Environ. Health, 20, 435–443.